2008
Autoantibodies against cyclophilin in systemic lupus erythematosus and Lyme disease
KRATZ A, HARDING MW, CRAFT J, MACKWORTH-YOUNG C, HANDSCHUMACHER RE. Autoantibodies against cyclophilin in systemic lupus erythematosus and Lyme disease. Clinical & Experimental Immunology 2008, 90: 422-427. PMID: 1458678, PMCID: PMC1554566, DOI: 10.1111/j.1365-2249.1992.tb05862.x.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAmino Acid IsomerasesAntibodies, Anti-IdiotypicAntibodies, MonoclonalAntibody SpecificityAutoantibodiesCarrier ProteinsChildEnzyme-Linked Immunosorbent AssayFamily HealthFemaleHumansImmunoglobulin GImmunoglobulin IdiotypesImmunoglobulin MLupus Erythematosus, SystemicLyme DiseaseMaleMiddle AgedPeptidylprolyl IsomeraseProtein DenaturationConceptsSystemic lupus erythematosusLupus erythematosusFirst-degree relativesLyme disease patientsMonoclonal IgM antibodyLupus patientsIgM antibodiesDisease patientsLepromatous leprosyImmune systemPatientsWestern blotLyme diseaseAntibodiesErythematosusAutoantibodiesHypergammaglobulinaemiaCyclophilinCyclosporinLeprosyDiseaseSerum
1996
Protective antibodies in murine Lyme disease arise independently of CD40 ligand.
Fikrig E, Barthold SW, Chen M, Grewal IS, Craft J, Flavell RA. Protective antibodies in murine Lyme disease arise independently of CD40 ligand. The Journal Of Immunology 1996, 157: 1-3. PMID: 8683101, DOI: 10.4049/jimmunol.157.1.1.Peer-Reviewed Original ResearchConceptsCD40L-deficient miceCD40 ligand-deficient miceMurine Lyme diseaseRegression of arthritisTransfer of serumDependent immune responsesIgG2b AbsAcute arthritisControl miceProtective antibodiesIg class switchingCD40 ligandImmune responseImmunodeficient miceLyme borreliosisLyme diseaseMiceBorrelia burgdorferiB. burgdorferiClass switchingArthritisBurgdorferiAbInfectionDisease
1995
Safety and Immunogenicity of an Outer Surface Protein A Vaccine in Subjects with Previous Lyme Disease
Schoen R, Meurice F, Brunet C, Cretella S, Krause D, Craft J, Fikrig E. Safety and Immunogenicity of an Outer Surface Protein A Vaccine in Subjects with Previous Lyme Disease. The Journal Of Infectious Diseases 1995, 172: 1324-1329. PMID: 7594671, DOI: 10.1093/infdis/172.5.1324.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntibodies, BacterialAntibody FormationAntigens, SurfaceBacterial Outer Membrane ProteinsBacterial VaccinesBorrelia burgdorferi GroupDose-Response Relationship, DrugEnzyme-Linked Immunosorbent AssayHumansImmunization ScheduleImmunoglobulin GLipoproteinsLyme DiseaseProspective StudiesSafetyVaccines, SyntheticConceptsSide effectsLyme diseaseOspA vaccinePrevious Lyme diseaseThree-dose scheduleLocal side effectsSystemic side effectsLyme vaccineMild arthralgiaVaccine doseThird doseProspective studyOspA antibodiesHealthy volunteersOuter surface proteinsVaccinePatientsDiseaseImmunogenicityDoseMonthsSubjectsSurface proteinsSafetyArthralgia
1992
Prevention of Lyme Disease after Tick Bites
Magid D, Schwartz B, Craft J, Schwartz J. Prevention of Lyme Disease after Tick Bites. New England Journal Of Medicine 1992, 327: 534-541. PMID: 1298217, DOI: 10.1056/nejm199208203270806.Peer-Reviewed Original ResearchConceptsTick biteProbability of infectionLyme diseaseOnly patientsEmpirical therapyErythema migransEmpirical treatmentBurgdorferi infectionAdditional minor complicationsMost major complicationsWeeks of doxycyclinePositive serologic testsDisease one monthEndemic Lyme diseaseBorrelia burgdorferi infectionB. burgdorferi infectionAdverse eventsMinor complicationsMost complicationsMajor complicationsEarly treatmentSerologic testsPatientsComplicationsInfection
1990
Lyme Disease
Rahn D, Craft J. Lyme Disease. Rheumatic Disease Clinics Of North America 1990, 16: 601-615. PMID: 2217960, DOI: 10.1016/s0889-857x(21)00890-5.Peer-Reviewed Original ResearchConceptsClinical expressionLyme diseaseB. burgdorferiPathogenesis of infectionProtean diseaseNeurologic diseaseCausative organismAreas of dermatologyInfectious organismsInfectious diseasesDisease persistenceDiseaseMolecular biologyClinical medicineBurgdorferiTick vectorExpressionRheumatologistsPatientsRheumatologyPathogenesisIllnessInfectionEpidemiologyCardiology
1986
Clinical manifestations of lyme disease
Steere A, Bartenhagen N, Craft J, Hutchinson G, Newman J, Pachner A, Rahn D, Sigal L, Taylor E, Malawista S. Clinical manifestations of lyme disease. International Journal Of Medical Microbiology 1986, 263: 201-205. PMID: 3554839, DOI: 10.1016/s0176-6724(86)80123-7.Peer-Reviewed Original ResearchConceptsMigratory musculoskeletal painErythema chronicum migransLyme diseaseMusculoskeletal painClinical manifestationsUnique skin lesionNon-productive coughDifferent clinical manifestationsFrank arthritisMononeuritis multiplexAcute myopericarditisCardiac involvementCranial neuritisSkin involvementUrticarial rashSore throatNeurologic abnormalitiesPeriorbital edemaAV blockDisease onsetSecondary lesionsSkin lesionsPatientsDiseaseLesionsAntigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness.
Craft JE, Fischer DK, Shimamoto GT, Steere AC. Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness. Journal Of Clinical Investigation 1986, 78: 934-939. PMID: 3531237, PMCID: PMC423723, DOI: 10.1172/jci112683.Peer-Reviewed Original ResearchConceptsIgG responsesIgM responseEarly diseaseLyme diseaseImmunoglobulin M responseImmunoglobulin G responseBorrelia burgdorferiSpirochetal antigensG responsesIgG antibodiesProlonged illnessPatientsM responseIllnessDiseaseAntigenB. burgdorferiMonthsLimited responseIgMBurgdorferiSuch responsesResponseArthritisYears
1984
Antibody Response in Lyme Disease: Evaluation of Diagnostic Tests
Craft J, Grodzicki R, Steere A. Antibody Response in Lyme Disease: Evaluation of Diagnostic Tests. The Journal Of Infectious Diseases 1984, 149: 789-795. PMID: 6373966, DOI: 10.1093/infdis/149.5.789.Peer-Reviewed Original ResearchConceptsEnzyme-linked immunosorbent assayAntibody responseLyme diseaseIgM antibodiesAntibody titersSpecific IgM antibody titersDiagnostic testsSpecific IgG antibody titersIgG antibody titersIgM antibody titersSerial serum samplesSpecific IgM antibodiesMonths of remissionCross-reactive antibodiesIxodes dammini spirocheteBetter diagnostic testsTiters of seraEarly diseaseControl subjectsAdsorption of serumPatientsSuch titersHigh titersDiseaseSerum samplesThe antibody response in Lyme disease.
Craft JE, Grodzicki RL, Shrestha M, Fischer DK, García-Blanco M, Steere AC. The antibody response in Lyme disease. The Yale Journal Of Biology And Medicine 1984, 57: 561-5. PMID: 6393607, PMCID: PMC2590019.Peer-Reviewed Original ResearchConceptsEnzyme-linked immunosorbent assayHumoral immune responseAntibody responseImmune responseIndirect immunofluorescenceLyme diseaseI. dammini spirocheteLyme arthritis patientsSpecific IgG responseSpecific IgM responseMonths of remissionSpecific IgM levelsIxodes dammini spirocheteLyme disease seraCross-reactive antibodiesTotal serum IgM.Lyme disease patientsAbsorption of seraArthritis patientsLyme arthritisIgG responsesIgM responseIgM levelsSpirochetal antigensDisease patientsRecovery of Lyme disease spirochetes from patients.
Steere AC, Grodzicki RL, Craft JE, Shrestha M, Kornblatt AN, Malawista SE. Recovery of Lyme disease spirochetes from patients. The Yale Journal Of Biology And Medicine 1984, 57: 557-60. PMID: 6393606, PMCID: PMC2589990.Peer-Reviewed Original Research
1983
The early clinical manifestations of Lyme disease.
Steere AC, Bartenhagen NH, Craft JE, Hutchinson GJ, Newman JH, Rahn DW, Sigal LH, Spieler PN, Stenn KS, Malawista SE. The early clinical manifestations of Lyme disease. Annals Of Internal Medicine 1983, 99: 76-82. PMID: 6859726, DOI: 10.7326/0003-4819-99-1-76.Peer-Reviewed Original ResearchConceptsLyme diseaseSkin lesionsElevated serum IgM levelsMigratory musculoskeletal painTick-transmitted spirochetesUnique skin lesionAspartate transaminase levelsEarly clinical manifestationsEarly Lyme diseaseSerum IgM levelsErythema chronicum migransMeningeal irritationLaboratory abnormalitiesNonproductive coughTransaminase levelsUrticarial rashMusculoskeletal painRegional lymphadenopathySkin manifestationsSore throatDermatologic manifestationsSerologic testingClinical manifestationsIgM levelsPeriorbital edemaTreatment of the early manifestations of Lyme disease.
Steere AC, Hutchinson GJ, Rahn DW, Sigal LH, Craft JE, DeSanna ET, Malawista SE. Treatment of the early manifestations of Lyme disease. Annals Of Internal Medicine 1983, 99: 22-6. PMID: 6407378, DOI: 10.7326/0003-4819-99-1-22.Peer-Reviewed Original ResearchConceptsEarly Lyme diseaseAdult patientsLyme diseaseMajor late complicationsPenicillin-treated patientsTetracycline-treated patientsAntibiotic regimensLate complicationsMajor complicationsMusculoskeletal painInitial severityLate symptomsEffective drugsPatientsEarly manifestationAntibiotic agentsComplicationsDiseaseSymptomsErythromycinPenicillinTetracyclinePainRegimensHeadacheThe Spirochetal Etiology of Lyme Disease
Steere A, Grodzicki R, Kornblatt A, Craft J, Barbour A, Burgdorfer W, Schmid G, Johnson E, Malawista S. The Spirochetal Etiology of Lyme Disease. New England Journal Of Medicine 1983, 308: 733-740. PMID: 6828118, DOI: 10.1056/nejm198303313081301.Peer-Reviewed Original ResearchConceptsLyme diseaseAntibody titersIgM titersSpecific IgM antibody titersSpecific IgG antibody titersElevated IgM titersI. dammini spirocheteIgG antibody titersIgM antibody titersTiters of IgGOnset of diseaseInfectious mononucleosisControl patientsImmunologic featuresIgG titersEarly diseaseControl subjectsSpirochetal etiologySkin lesionsCerebrospinal fluidPatientsLate manifestationSixth weekDiseaseTiters